Maartje van den Biggelaar: LSBR Awarded Our Consortium the LSBR Anniversary Grant of €1.6 Million to Launch HemoTwin-BD
Maartje van den Biggelaar, Head of laboratory of Proteomics at Sanquin, shared a post on LinkedIn:
“Proteomics of hemostasis
Extremely proud and happy that The Landsteiner Foundation for Blood Transfusion Research (LSBR) awarded our consortium the LSBR Anniversary Grant of €1.6 million to launch HemoTwin-BD, a multidisciplinary program to unravel why patients with inherited bleeding disorders or an unexplained bleeding tendency can have very different bleeding phenotypes.
This grant gives us the opportunity to combine large national patient studies and scientific expertise to investigate how genetic variationtranslates into proteoforms that shape the hemostatic potential. Using AI-based modelling we will build digital twins to uncover new biological mechanisms and ultimately pave the way for more personalized and safer treatment strategies.
A big thank you to all consortium partners—from clinical experts and fundamental researchers to data scientists—and to The Landsteiner Foundation for Blood Transfusion Research (LSBR) for their trust in our work.”

Stay updated with Hemostasis Today.
-
Jan 16, 2026, 06:05Wolfgang Miesbach on Jacob Lund’s Study: How to Define FVIII Bioequivalence
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor
-
Jan 16, 2026, 04:51Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease
-
Jan 16, 2026, 04:48Reza Shojaei on Plasma Donation as Life-Changing Medicine in Motion
-
Jan 16, 2026, 04:11Open-Label Extension Study of Marstacimab: Pfizer Has Reported a Fatal Event
-
Jan 16, 2026, 04:11Why is DVT More Common In the Left Leg? Dr Raheel Moazzam’s New Study Gives Answers!
